Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Amifostine in Treating Patients With Cancer Who Have Neurological Changes Caused by Chemotherapy

This study has been completed.
Sponsor:
Information provided by:
National Cancer Institute (NCI)
ClinicalTrials.gov Identifier:
NCT00003252
First received: November 1, 1999
Last updated: March 25, 2013
Last verified: April 2000
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: September 2004
  Estimated Primary Completion Date: No date given